Ambu A/S (OTCMKTS:AMBBY) Hits New 1-Year Low – Here’s Why

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY)’s share price hit a new 52-week low during trading on Tuesday . The stock traded as low as $11.92 and last traded at $11.92, with a volume of 106 shares trading hands. The stock had previously closed at $12.84.

Ambu A/S Stock Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.86. The company has a market capitalization of $2.70 billion, a P/E ratio of 37.06 and a beta of 0.98. The company’s fifty day simple moving average is $13.32 and its 200-day simple moving average is $14.27.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $0.07 EPS for the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%. The business had revenue of $242.85 million during the quarter.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.